The correlation between primary open-angle glaucoma (POAG) and gut microbiota: a pilot study towards predictive, preventive, and personalized medicine

被引:13
|
作者
Chen, Si [1 ,2 ,3 ]
Wang, Nan [1 ,2 ,3 ]
Xiong, Siqi [1 ,2 ,3 ]
Xia, Xiaobo [1 ,2 ,3 ]
机构
[1] Cent South Univ, Eye Ctr Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[2] Hunan Key Lab Ophthalmol, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Glaucoma; Gut microbiota; Macrophages; Inflammation; Laboratory medicine; Biomarkers; Predictive preventive personalized medicine (PPPM; 3PM); TRABECULAR MESHWORK; CLOSURE GLAUCOMA; INFLAMMATION; PROGRESSION; EXPRESSION; ROLES; CELLS; EYE;
D O I
10.1007/s13167-023-00336-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundGlaucoma is the leading cause of irreversible blindness worldwide. Emerged evidence has shown that glaucoma is considered an immune system related disorder. The gut is the largest immune organ in the human body and the gut microbiota (GM) plays an irreversible role in maintaining immune homeostasis. But, how the GM influences glaucoma remains unrevealed. This study aimed at investigating the key molecules/pathways mediating the GM and the glaucoma to provide new biomarkers for future predictive, preventive, and personalized medicine.MethodsDatasets from the primary open-angle glaucoma (POAG) patients (GSE138125) and datasets for target genes of GM/GM metabolites were downloaded from a public database. For GSE138125, the differentially expressed genes (DEGs) between healthy and POAG samples were identified. And the online Venn diagram tool was used to obtain the DEGs from POAG related to GM. After which GM-related DEGs were analyzed by correlation analysis, pathway enrichment analysis, and protein-protein interaction (PPI) network analysis. Human trabecular meshwork cells were used for validation, and the mRNA level of hub genes was verified by quantitative real-time polymerase chain reaction (RT-qPCR) in the in vitro glaucoma model.ResultsA total of 16 GM-related DEGs in POAG were identified from the above 2 datasets (9 upregulated genes and 7 downregulated genes). Pathway enrichment analysis indicated that these genes are mostly enriched in immune regulation especially macrophages-related pathways. Then 6 hub genes were identified by PPI network analysis and construction of key modules. Finally, RT-qPCR confirmed that the expression of the hub genes in the in vitro glaucoma model was consistent with the results of bioinformatics analysis of the mRNA chip.ConclusionThis bioinformatic study elucidates NFKB1, IL18, KITLG, TLR9, FKBP2, and HDAC4 as hub genes for POAG and GM regulation. Immune response modulated by macrophages plays an important role in POAG and may be potential targets for future predictive, preventive, and personalized diagnosis and treatment.
引用
收藏
页码:539 / 552
页数:14
相关论文
共 50 条
  • [41] Correlation between peripapillary retinal nerve fiber layer thickness and fundus autofluorescence in primary open-angle glaucoma
    Reznicek, Lukas
    Seidensticker, Florian
    Mann, Thomas
    Huebert, Irene
    Buerger, Alexandra
    Haritoglou, Christos
    Neubauer, Aljoscha S.
    Kampik, Anselm
    Hirneiss, Christoph
    Kernt, Marcus
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1883 - 1888
  • [42] Detection of serum uric acid in primary open angle glaucoma: A pilot study
    Serra, Rita
    Coscas, Florence
    Pinna, Antonio
    Peri, Marcella
    Zucca, Ignazio
    Sellam, Alexandre
    Giancipoli, Ermete
    Boscia, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (04) : 1857 - 1861
  • [43] Comparison of MicroRNA Expression in Aqueous Humor of Normal and Primary Open-Angle Glaucoma Patients Using PCR Arrays: A Pilot Study
    Jayaram, Hari
    Phillips, Jay I.
    Lozano, Diana C.
    Choe, Tiffany E.
    Cepurna, William O.
    Johnson, Elaine C.
    Morrison, John C.
    Gattey, Devin M.
    Saugstad, Julie A.
    Keller, Kate E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 2884 - 2890
  • [44] The association between cigarette smoking and primary open-angle glaucoma: a systematic review
    Vageesh Jain
    Mishank Jain
    Mohammed M. Abdull
    Andrew Bastawrous
    International Ophthalmology, 2017, 37 : 291 - 301
  • [45] Determination of Serum Ceruloplasmin Concentration in Patients with Primary Open Angle Glaucoma with Cataract and Patients with Cataract Only: A Pilot Study
    Sarnat-Kucharczyk, Monika
    Rokicki, Wojciech
    Zalejska-Fiolka, Jolanta
    Pojda-Wilczek, Dorota
    Mrukwa-Kominek, Ewa
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1384 - 1388
  • [46] On the relationship between age and prevalence and/or incidence of primary open-angle glaucoma in the "Salzburg-Moorfields Collaborative Glaucoma Study"
    Hitzl, W.
    Hornykewycz, K.
    Grabner, G.
    Reitsamer, H. A.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (02) : 115 - 119
  • [47] 10-year outcomes of first-line selective laser trabeculoplasty (SLT) for primary open-angle glaucoma (POAG)
    Ejaz Ansari
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 1597 - 1604
  • [48] Progression of Visual Pathway Degeneration in Primary Open-Angle Glaucoma: A Longitudinal Study
    Haykal, Shereif
    Jansonius, Nomdo M.
    Cornelissen, Frans W.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [49] Severe Primary Open-Angle Glaucoma and Agricultural Profession: A Retrospective Cohort Study
    Grosselin, Mathilde
    Bouazzi, Leila
    Ferreira de Moura, Thomas
    Arndt, Carl
    Thorigny, Maxime
    Sanchez, Stephane
    Denoyer, Alexandre
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (02)
  • [50] A Systematic Review of Micropulse Laser Trabeculoplasty (MLT) in Primary Open-Angle Glaucoma (POAG) Management: Efficacy, Safety, and Future Perspectives
    Confalonieri, Filippo
    Casarini, Barbara
    Papapicco, Annalaura
    Stiro, Fabio
    Piscopo, Raffaele
    D'Andrea, Luca
    Petrovski, Goran
    Verdina, Tommaso
    BIOMEDICINES, 2025, 13 (01)